CompletedNCT05227612
Psilocybin combined with cognitive therapy for depression
About this title
Read the official source — NCT05227612Medication studyAges 21–60United States
Understand this study
Who was this study for?
Listed age limits: 21 years to 60 years.
- Listed locations
- Los AngelesSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateStarted: June 27, 2023
- Recruitment status
- Completed
- Enrollment listed in the registry
- 16
- Sponsor
- University of California, Los Angeles
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- From 21 Years to 60 Years
- Official registry ID
- NCT05227612
- Official title
Show the full official title
Psilocybin-assisted Cognitive Behavioral Therapy for Depression
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Los Angeles
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of California, Los Angeles, a university.
Did this study involve medication?
Yes. The study involved medication, including Psilocybin.
Who was this study for?
Listed age limits: 21 years to 60 years.
